FDA Adverse Event Injury Summary report: N

STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

MDR report key: 22405274 · Received July 4, 2025

Report

Report Number
3006630150-2025-05178
Event Type
Injury
Date Received
July 4, 2025
Date of Event
June 6, 2025
Report Date
March 26, 2026
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Product Code
NHL
UDI-DI
08714729966395
PMA / PMN Number
P150031
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-IPG-R-MRI UPN: M365DB12320, MODEL: DB-1232, SERIAL: (B)(6), BATCH: (B)(6), UDI: (B)(4). PRODUCT FAMILY: UPN: M365DB2203450, MODEL: DB-2203-45, SERIAL: (B)(6), BATCH: (B)(6), UDI: (B)(4). PRODUCT FAMILY: UPN: M365DB3216550, MODEL: DB-3216-55, SERIAL: (B)(6), BATCH: (B)(6), UDI: (B)(4).

Additional Manufacturer Narrative · 0

CORRECTION TO BLOCKS: B2, H6. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-IPG-R-MRI UPN: M365DB12320 MODEL: DB-1232 SERIAL: (B)(6). BATCH: 553835 UDI: (B)(4). PRODUCT FAMILY: UPN: M365DB2203450 MODEL: DB-2203-45 SERIAL: (B)(6). BATCH: 5002318 UDI: (B)(4). PRODUCT FAMILY: UPN: M365DB3216550 MODEL: DB-3216-55 SERIAL: (B)(6). BATCH: 5001458 UDI: (B)(4).

Additional Manufacturer Narrative · 0

THE DEVICES WERE RETAINED BY THE FACILITY AND NOT RETURNED FOR ANALYSIS; THEREFORE, A TECHNICAL ANALYSIS COULD NOT BE PERFORMED. A REVIEW OF THE DEVICE HISTORY RECORD (DHR) WAS PERFORMED. THE REVIEW OF THE DHR IDENTIFIED THAT THERE WERE NO PROCESS RELATED NON-CONFORMANCES, SCRAP, OR REWORK PERFORMED DURING THE PRODUCTION THAT COULD EXPLAIN THE EVENT. THE REVIEWS ENSURE EACH DEVICE MEETS SPECIFICATION PRIOR TO RELEASE FOR USE. THERE IS NO INDICATION THE DEVICE MANUFACTURING PROCESS CONTRIBUTED TO THE REPORTED COMPLAINT. A LABELING REVIEW WAS PERFORMED ON THE DEVICE'S INSTRUCTIONS FOR USE (IFU). THERE IS NO EVIDENCE THAT THE DEVICE WAS USED IN A MANNER INCONSISTENT WITH THE LABELLED INDICATIONS. BASED ON A THOROUGH REVIEW OF THE REPORTED COMPLAINT, BOSTON SCIENTIFIC HAS ASSIGNED AN INVESTIGATION CONCLUSION CODE OF KNOWN INHERENT RISK OF DEVICE.

Additional Manufacturer Narrative · 0

CORRECTION TO BLOCKS: B2, H6. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-IPG-R-MRI, UPN: M365DB12320, MODEL: DB-1232, SERIAL: (B)(6), BATCH: 553835, UDI: (B)(4). PRODUCT FAMILY: UPN: M365DB2203450, MODEL: DB-2203-45, SERIAL: (B)(6), BATCH: 5002318, UDI: (B)(4). PRODUCT FAMILY: UPN: M365DB3216550, MODEL: DB-3216-55, SERIAL: (B)(6), BATCH: 5001458, UDI: (B)(4).

Description of Event or Problem · 0

IT WAS REPORTED THAT THE DEEP BRAIN STIMULATION (DBS) PATIENT UNDERWENT AN EXPLANT PROCEDURE INVOLVING COMPLETE REMOVAL OF THE DBS SYSTEM DUE TO INFECTION. THE PATIENT EXHIBITED FLUID DISCHARGE AT THE EXTENSION SITE. THE PATIENT REMAINS IN RECOVERY, AND ANTIBIOTIC THERAPY WAS INITIATED TO MANAGE THE INFECTION. THE HOSPITAL HAS RETAINED THE EXPLANTED DEVICES, AND THEY WILL NOT BE RETURNED FOR ANALYSIS.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE DEEP BRAIN STIMULATION (DBS) PATIENT UNDERWENT AN EXPLANT PROCEDURE INVOLVING COMPLETE REMOVAL OF THE DBS SYSTEM DUE TO INFECTION. THE PATIENT EXHIBITED FLUID DISCHARGE AT THE EXTENSION SITE. THE PATIENT REMAINS IN RECOVERY, AND ANTIBIOTIC THERAPY WAS INITIATED TO MANAGE THE INFECTION. THE HOSPITAL HAS RETAINED THE EXPLANTED DEVICES, AND THEY WILL NOT BE RETURNED FOR ANALYSIS.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE DEEP BRAIN STIMULATION (DBS) PATIENT UNDERWENT AN EXPLANT PROCEDURE INVOLVING COMPLETE REMOVAL OF THE DBS SYSTEM DUE TO INFECTION. THE PATIENT EXHIBITED FLUID DISCHARGE AT THE EXTENSION SITE. THE PATIENT REMAINS IN RECOVERY, AND ANTIBIOTIC THERAPY WAS INITIATED TO MANAGE THE INFECTION. THE HOSPITAL HAS RETAINED THE EXPLANTED DEVICES, AND THEY WILL NOT BE RETURNED FOR ANALYSIS.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE DEEP BRAIN STIMULATION (DBS) PATIENT UNDERWENT AN EXPLANT PROCEDURE INVOLVING COMPLETE REMOVAL OF THE DBS SYSTEM DUE TO INFECTION. THE PATIENT EXHIBITED FLUID DISCHARGE AT THE EXTENSION SITE. THE PATIENT REMAINS IN RECOVERY, AND ANTIBIOTIC THERAPY WAS INITIATED TO MANAGE THE INFECTION. THE HOSPITAL HAS RETAINED THE EXPLANTED DEVICES, AND THEY WILL NOT BE RETURNED FOR ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
484344 STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS NHL BOSTON SCIENTIFIC NEUROMODULATION CORPORATION DB-3216-55 5001779 08714729966395

Patients

Seq Age Sex Outcome Treatment
1 82 YR Female Hospitalization| R